TrialProstate cancer and prostatic diseases2023

Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD.

Ronald de Wit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.